Company press releases

Displaying 1 - 50 of 190 results
Released Company Title Industry Topic
02 Dec 2025
22:00 CET 		DBV TECHNOLOGIES Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 20103010 Biotechnology Other subject
02 Dec 2025
22:00 CET 		DBV TECHNOLOGIES Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2025 20103010 Biotechnology Other subject
12 Nov 2025
05:50 CET 		DBV TECHNOLOGIES DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years 20103010 Biotechnology Other subject
12 Nov 2025
05:50 CET 		DBV TECHNOLOGIES DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux arachides 20103010 Biotechnology Other subject
04 Nov 2025
22:30 CET 		DBV TECHNOLOGIES DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation 20103010 Biotechnology Other subject
04 Nov 2025
22:30 CET 		DBV TECHNOLOGIES DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference 20103010 Biotechnology Other subject
03 Nov 2025
22:30 CET 		DBV TECHNOLOGIES DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial 20103010 Biotechnology Other subject
03 Nov 2025
22:30 CET 		DBV TECHNOLOGIES DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer 20103010 Biotechnology Other subject
03 Nov 2025
22:25 CET 		DBV TECHNOLOGIES Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2025 20103010 Biotechnology Other subject
03 Nov 2025
22:25 CET 		DBV TECHNOLOGIES Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 20103010 Biotechnology Other subject
30 Oct 2025
21:30 CET 		DBV TECHNOLOGIES DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration 20103010 Biotechnology Other subject
30 Oct 2025
21:30 CET 		DBV TECHNOLOGIES DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors 20103010 Biotechnology Other subject
30 Oct 2025
08:00 CET 		DBV TECHNOLOGIES DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting 20103010 Biotechnology Other subject
30 Oct 2025
08:00 CET 		DBV TECHNOLOGIES DBV Technologies participe au congrès scientifique annuel de l'ACAAI 20103010 Biotechnology Other subject
29 Oct 2025
23:47 CET 		DBV TECHNOLOGIES DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq 20103010 Biotechnology Other subject
29 Oct 2025
23:47 CET 		DBV TECHNOLOGIES DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq 20103010 Biotechnology Other subject
28 Oct 2025
21:25 CET 		DBV TECHNOLOGIES DBV Technologies Reports Third Quarter 2025 Financial Results 20103010 Biotechnology Other subject
28 Oct 2025
21:25 CET 		DBV TECHNOLOGIES DBV Technologies publie ses résultats financiers du troisième trimestre 2025 20103010 Biotechnology Other subject
06 Oct 2025
23:02 CEST 		DBV TECHNOLOGIES DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq 20103010 Biotechnology Other subject
06 Oct 2025
23:02 CEST 		DBV TECHNOLOGIES DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq 20103010 Biotechnology Other subject
18 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies Announces Resignation of Board Member 20103010 Biotechnology Other subject
18 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies annonce la démission d’un membre de son Conseil d’administration 20103010 Biotechnology Other subject
05 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq 20103010 Biotechnology Other subject
05 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq 20103010 Biotechnology Other subject
03 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference 20103010 Biotechnology Other subject
03 Sep 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment 20103010 Biotechnology Other subject
01 Aug 2025
22:05 CEST 		DBV TECHNOLOGIES Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2025 20103010 Biotechnology Other subject
01 Aug 2025
22:05 CEST 		DBV TECHNOLOGIES Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 20103010 Biotechnology Other subject
29 Jul 2025
22:17 CEST 		DBV TECHNOLOGIES DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report 20103010 Biotechnology Other subject
29 Jul 2025
22:17 CEST 		DBV TECHNOLOGIES DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation 20103010 Biotechnology Other subject
29 Jul 2025
22:08 CEST 		DBV TECHNOLOGIES DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 20103010 Biotechnology Other subject
29 Jul 2025
22:08 CEST 		DBV TECHNOLOGIES DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results 20103010 Biotechnology Other subject
28 Jul 2025
22:30 CEST 		DBV TECHNOLOGIES Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF 20103010 Biotechnology Other subject
28 Jul 2025
22:30 CEST 		DBV TECHNOLOGIES Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF 20103010 Biotechnology Other subject
22 Jul 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines 20103010 Biotechnology Other subject
22 Jul 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer 20103010 Biotechnology Other subject
25 Jun 2025
22:15 CEST 		DBV TECHNOLOGIES DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. 20103010 Biotechnology Other subject
25 Jun 2025
22:15 CEST 		DBV TECHNOLOGIES DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old 20103010 Biotechnology Other subject
12 Jun 2025
22:05 CEST 		DBV TECHNOLOGIES DBV Technologies to Participate in Upcoming EAACI Congress 2025 20103010 Biotechnology Other subject
12 Jun 2025
22:05 CEST 		DBV TECHNOLOGIES DBV Technologies participera au prochain congrès EAACI 2025 20103010 Biotechnology Other subject
11 Jun 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting 20103010 Biotechnology Other subject
11 Jun 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025 20103010 Biotechnology Other subject
04 Jun 2025
22:32 CEST 		DBV TECHNOLOGIES Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025 20103010 Biotechnology Other subject
04 Jun 2025
22:32 CEST 		DBV TECHNOLOGIES Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025 20103010 Biotechnology Other subject
03 Jun 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document 20103010 Biotechnology Other subject
03 Jun 2025
22:30 CEST 		DBV TECHNOLOGIES DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 20103010 Biotechnology Other subject
15 May 2025
22:30 CEST 		DBV TECHNOLOGIES Combined General Meeting of June 11, 2025 20103010 Biotechnology Other subject
15 May 2025
22:30 CEST 		DBV TECHNOLOGIES Assemblée Générale Mixte du 11 juin 2025 20103010 Biotechnology Other subject
06 May 2025
22:30 CEST 		DBV TECHNOLOGIES Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025 20103010 Biotechnology Other subject
06 May 2025
22:30 CEST 		DBV TECHNOLOGIES Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 20103010 Biotechnology Other subject